Transient respiratory failure possibly associated to imatinib.
Lengerke
C
C
Brümmendorf
T
T
Herrlinger
U
U
Horger
M
M
Kanz
L
L
Hartmann
J T
JT
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012131:Respiratory Insufficiency / Q000139:chemically induced*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate
N Engl J Med. 2002 Aug 15;347(7):472-80
12181401
J Clin Oncol. 2003 Dec 1;21(23):4342-9
14645423
Anesth Prog. 1997 Fall;44(4):132-41
9481957
Lancet. 2002 May 18;359(9319):1751-2
12049868
J Clin Oncol. 2000 Sep 15;18(18):3211-20
10986053
Lancet. 2001 Oct 27;358(9291):1421-3
11705489
Hum Pathol. 2002 May;33(5):478-83
12094372